We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
divider
Anyone can get Melanoma regardless of race or color. As part of the Bristol Myers Squibb (BMS) commitment to patient care, we continue to explore Melanoma through extensive clinical research. Learn more about our clinical research studies below.
divider
Approved medications are available that can slow the progression of Melanoma. However, not all melanomas respond, and the side effects sometimes outweigh the benefits. That's why researchers are working hard to develop more options - like those under investigation in our clinical research program. On this page you'll find information about Melanoma clinical trials for patients of all ethnicities and skin colors and active clinical trials.
If you are interested in participating in a clinical trial, you have the following options:
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
A recent study of 649 people showed that
32% of Black patients
were diagnosed with Stage 3 or Stage 4 disease1
13% of White patients
were similarly diagnosed at such a late stage.
Research has shown that patients with skin of color are less likely than White patients to survive Melanoma.2
A research study has shown that the 5-year survival rates for skin cancer for the non-white population is
70% as compared to
92% for white patients.3
People with darker skin are more likely to get Melanoma in areas that don’t receive much sun exposure, such as thesole of your feet, palms of your hands, and fingernail beds.
Clinical Trials in Detail
Our "Participant's Discussion Guide to Cancer Clinical Trials" has information about how clinical trials work.
Discussing Melanoma with Your Doctor
Topics you might want to discuss with your doctor,
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information